C12Y 304/21002
Chymotrypsin c
Official title: Chymotrypsin C (3.4.21.2)
C12Y304/21002 (Chymotrypsin c) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 10
- Assignees
- 7
- Inventors
- 20
- Latest grant
- 20 Aug 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 2 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Reduced-pressure treatment systems and methods employing debridement mechanisms20 Aug 2019US 10,383,923 B2KCI Licensing, Inc.
- Reduced-pressure treatment systems and methods employing debridement mechanisms15 Nov 2016US 9,492,324 B2KCI Licensing, Inc.
- Reduced-pressure treatment systems and methods employing debridement mechanisms9 Aug 2016US 9,408,750 B2KCI Licensing, Inc.
- Reduced-pressure treatment systems and methods employing debridement mechanisms8 Dec 2015US 9,205,000 B2KCI Licensing, Inc.
- Reduced-pressure treatment systems and methods employing debridement mechanisms16 Jul 2013US 8,486,032 B2KCI Licensing, Inc.
- Pharmaceutical composition for treating and/or preventing cancer20 Aug 2026US 2026/0240962 A1Toray Industries, Inc.
- Composition containing digestive enzymes and nutrients suitable for enteral administration23 Oct 2025US 2025/0325012 A1Allergan Pharmaceuticals International Limited
- Methods for decellularizing human omentum and products generated therefrom18 Sep 2025US 2025/0290036 A1Matricelf Ltd.
- Composition containing digestive enzymes and nutrients suitable for enteral administration16 Jul 2020US 2020/0221748 A1Allergan Pharmaceuticals International Limited
- Reduced-pressure treatment systems and methods employing debridement mechanisms2 Feb 2017US 2017/0028037 A1KCI Licensing, Inc.
Most cited
By later US patents